» Articles » PMID: 12799361

Detailed Structural Analysis of the Peptidoglycan of the Human Pathogen Neisseria Meningitidis

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2003 Jun 12
PMID 12799361
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

We used reverse-phase high pressure liquid chromatography (HPLC), matrix-assisted laser desorption ionization mass spectrometry (MALDI-MS) and post source decay analysis (MALDI-PSD) to determine the muropeptide composition of the human pathogen Neisseria meningitidis. Structural assignment was determined for 28 muropeptide species isolated after HPLC separation and purification. Fourteen of these muropeptides were O-acetylated to different degrees. We identified the entire O-acetylation spectrum of dimers and trimers both in muropeptides and 1,6-anhydromuropeptides. On average, one of three disaccharides was O-acetylated. Furthermore, the degree of cross-linking of the N. meningitidis peptidoglycan was around 39% in all the strains analyzed. MALDI-PSD analysis of several muropeptide species indicated that meningococci only synthesize D-alanyl-meso-diaminopimelate cross-bridges. No muropeptides representative of covalent linkages of lipoproteins to the peptidoglycan could be identified, unlike in Escherichia coli. Finally, comparison of the muropeptide composition of penicillin-susceptible and penicillin-intermediate clinical strains of meningococci showed a positive correlation between the minimum inhibitory concentration (MIC) of penicillin G and the amount of muropeptides carrying an intact pentapeptide chain in the peptidoglycan. This suggests that reduced susceptibility to penicillin G in N. meningitidis is associated with a decrease in d,d-carboxypeptidase activity and/or D,D-transpeptidase activity.

Citing Articles

accumulate in large organs during meningococcal sepsis.

Brusletto B, Hellerud B, Ovstebo R, Brandtzaeg P Front Cell Infect Microbiol. 2023; 13:1298360.

PMID: 38089821 PMC: 10713808. DOI: 10.3389/fcimb.2023.1298360.


Postbiotics as potential new therapeutic agents for sepsis.

Lou X, Xue J, Shao R, Mo C, Wang F, Chen G Burns Trauma. 2023; 11:tkad022.

PMID: 37334140 PMC: 10271603. DOI: 10.1093/burnst/tkad022.


Bacterial subversion of NLR-mediated immune responses.

Kienes I, Johnston E, Bitto N, Kaparakis-Liaskos M, Kufer T Front Immunol. 2022; 13:930882.

PMID: 35967403 PMC: 9367220. DOI: 10.3389/fimmu.2022.930882.


The Pathogenic Neisseria Use a Streamlined Set of Peptidoglycan Degradation Proteins for Peptidoglycan Remodeling, Recycling, and Toxic Fragment Release.

Schaub R, Dillard J Front Microbiol. 2019; 10:73.

PMID: 30766523 PMC: 6365954. DOI: 10.3389/fmicb.2019.00073.


The low-molecular-mass, penicillin-binding proteins DacB and DacC combine to modify peptidoglycan cross-linking and allow stable Type IV pilus expression in Neisseria gonorrhoeae.

Obergfell K, Schaub R, Priniski L, Dillard J, Seifert H Mol Microbiol. 2018; 109(2):135-149.

PMID: 29573486 PMC: 6153085. DOI: 10.1111/mmi.13955.